Projects - Drug Development Technology

Drug Development Technology is using cookies

We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.

ContinueLearn More X

X

Advertise with us

Poteligeo®

Poteligeo for the Treatment of Mycosis Fungoides and Sezary Syndrome

Poteligeo® (mogamulizumab-kpkc) is a monoclonal antibody (mAb) indicated for the treatment of mycosis fungoides and Sézary syndrome in adults.

Vizimpro®

Vizimpro (dacomitinib) for the Treatment of Non-Small Cell Lung Cancer

Elzonris

Elzonris (tagraxofusp-erzs) for the Treatment of BPDCN

Inbrija

Inbrija for the Treatment of OFF Episodes in Parkinson’s Disease

ASP-1929

ASP-1929 for the Treatment of Head and Neck Squamous Cell Carcinomas

# A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Filter by:

Projects by Region: Europe

Cablivi (caplacizumab) for the Treatment of Acquired Thrombotic Thrombocytopenic Purpura

Cablivi (caplacizumab) is a bivalent anti-Von Willebrand factor (vWF) nanobody indicated for the treatment of...
Read More...

Carnexiv (carbamazepine) for the Treatment of Certain Seizure Types in Adults

Carnexiv (carbamazepine) is an injectable formulation developed by Lundbeck for partial, generalised tonic-clonic seizures in...
Read More...